Chinese doctors trial plasma therapy on COVID-19 patients

WHO has backed the therapy using convalescent plasma as a 'valid approach'

Doctors in Shanghai are using hyperimmune globulin from plasma of patients who have recovered from COVID-19 to treat those fighting the infection, with some “encouraging preliminary results”.